Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 ResultsPRNewsWire • 01/05/24
These Two Stocks Rocked During 2023 And Are Stretching To New HighsInvestors Business Daily • 12/29/23
Boston Scientific Initiates AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial FibrillationPRNewsWire • 12/28/23
NACD New England honors Waters Corp. and Devoted Health as Public and Private Company “Boards of the Year”Business Wire • 12/18/23
Billionaire Ken Griffin's Citadel Returned a Whopping $7 Billion to Investors -- These Are 3 of Its Biggest HoldingsThe Motley Fool • 12/14/23
Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion DealSeeking Alpha • 11/12/23
Boston Scientific Inches Closer To A Breakout After Eking Out A Third-Quarter BeatInvestors Business Daily • 10/26/23